Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
This guide outlines what to buy as a crypto beginner starter pack, focusing on simple, diversified picks and why they matter for new investors.
12,957 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Palantir stock just popped on fresh bullish whispers and government momentum. This guide breaks down the drivers, ris...
Qualcomm is navigating a tough start to 2026. A memory crunch, potential shifts with Apple, and a large buyback are m...
In 2026, many adults and teens feel pressure from online peers to keep up with trends, upgrade gadgets, or join paid ...
Celcuity stock popped today after the company released its 2025 results, showing a tighter quarterly loss despite no ...
New Jersey’s real estate scene is buzzing even with steep taxes and living costs. This article breaks down the demand...
Uber’s first-quarter results sparked a rare split on Wall Street: Goldman Sachs trims the stock target, while Piper S...
Stocks all-time highs still attract buyers as earnings momentum and AI-driven demand support another leg up. Here's t...
Eli Lilly's ascent to the top of the drug charts centers on a single family of medicines. This article breaks down wh...
Market pullbacks can wipe out gains, but some AI leaders actually gain momentum as fear rises. Learn how to spot a st...
In May 2026, two fresh tech IPOS are catching the eye of diligent investors. This guide breaks down why they stand ou...
A china-focused fund cuts million from Mattel in a first-quarter move. This article explains why such moves happen, w...